Results 141 to 150 of about 43,257 (252)

End-Stage Renal Disease Treatment Choices Model and Use of Home Dialysis and Kidney Transplant.

open access: yesJAMA Health Forum
Dixit MN   +12 more
europepmc   +1 more source

Addressing the inequity of access to home Dialysis in Europe: recommendations for action informed by an international consensus exercise. [PDF]

open access: yesBMC Nephrol
Davies SJ   +15 more
europepmc   +1 more source

Validation of the Arabic Version of Patient Health Questionnaire‐9 in Omani and Yemeni Patients With Chronic Physical Diseases

open access: yesInternational Journal of Methods in Psychiatric Research, Volume 35, Issue 3, September 2026.
ABSTRACT Background Secondary depression frequently develops in people with chronic diseases, and it may hinder disease progress and treatment outcomes. This study aimed to examine the construct validity and measurement invariance of the Arabic version of the Patient Health Questionnaire‐9 (PHQ‐9) among patients with chronic physical conditions ...
Amira Mohammed Ali   +14 more
wiley   +1 more source

A Province-Wide Home Dialysis Program Review: Challenges, Strengths, and Future Strategies. [PDF]

open access: yesCan J Kidney Health Dis
Borkum M   +8 more
europepmc   +1 more source

x‐Ray Structure of Streptomyces avermitilis Phospholipase D Reveals a Ca2+‐Stabilized Expanded Active‐Site Cleft Adapted for Phospholipid Binding

open access: yesProteins: Structure, Function, and Bioinformatics, Volume 94, Issue 9, Page 1543-1550, September 2026.
ABSTRACT Phospholipase D (PLD) catalyzes the hydrolysis of phospholipids to generate phosphatidic acid and free head groups such as choline. Among bacterial PLD enzymes, Streptomyces chromofuscus PLD (SchPLD), a member of the alkaline phosphatase D (PhoD) superfamily, exhibits unique Ca2+‐dependent phospholipase activity.
Yoshiaki Yasutake   +6 more
wiley   +1 more source

Unveiling Challenges Hindering the Growth of Home Dialysis in Finland: Insights From 40 Years of Experience. [PDF]

open access: yesHemodial Int
Fuentes Huertas B   +6 more
europepmc   +1 more source

The Changing Landscape of Hantavirus Infections: A Narrative Review of Epidemiology, Pathogenesis, and Countermeasures

open access: yesReviews in Medical Virology, Volume 36, Issue 5, September 2026.
ABSTRACT Hantaviruses are emerging zoonotic pathogens of increasing global public health significance. Their epidemiological landscape is rapidly changing due to ecological disruption, climate variability, urbanisation, and evolving human–animal interfaces.
Francesco De Maria   +5 more
wiley   +1 more source

Blurring Clinical and Best Interests Decisions: Townsend v Epsom and St Helier University Hospitals NHS Trust

open access: yesThe Modern Law Review, Volume 89, Issue 5, Page 815-832, September 2026.
Healthcare decision‐making under the Mental Capacity Act 2005 (MCA 2005) has long been understood as comprising two distinct, sequential decisions. First, a clinical decision about what treatment options are available. Second, a best interests decision about which (if any) of these options to proceed with.
Jordan A. Parsons, Alex Cisneros
wiley   +1 more source

Neighborhood Built Environment and Home Dialysis Utilization: Varying Patterns by Urbanicity-Dependent Patterns and Implications for Policy. [PDF]

open access: yesAm J Kidney Dis
Kim B   +12 more
europepmc   +1 more source

Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant‐Level Exploratory Analysis of the Randomised CONFIDENCE Trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 7964-7973, September 2026.
ABSTRACT Aims This prespecified analysis evaluated whether the safety and efficacy of finerenone and a sodium–glucose cotransporter 2 inhibitor (SGLT2i) combination vary by baseline glycated haemoglobin (HbA1c). Materials and Methods Adults with type 2 diabetes and a urinary albumin‐to‐creatinine ratio (UACR) of 100 − < 5000 mg/g, estimated glomerular ...
Janet B. McGill   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy